The European Medicines Agency (EMA) spent most of 2017 trying to navigate how to deal with the UK’s move out of the EU, the agency’s own move to Amsterdam (with an eye toward being operational by 30 ...
Like the US Food and Drug Administration (FDA), the European Medicines Agency (EMA) saw an increase in the number of new drugs and biologics it recommended for marketing authorization in 2017. Looking ...
Starting in April 2017, the European Medicines Agency (“EMA”) will expand the Multinational Assessment Team (“MNAT”) Initiative to post-authorisation assessments. From this date, the MNAT Initiative ...
The European Medicines Agency (EMA) recommended approval for 35 new therapeutic agents last year, compared with 27 in 2016 and 39 in 2015. The EMA's count includes small molecules, antibodies, ...
The European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) are likely sign a pact for mutual recognition of drug facility inspections in January 2017. In the wake of this ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results